期刊文献+

快速灵敏检测HCV核心抗原的免疫新方法及其性能分析 被引量:4

下载PDF
导出
摘要 目的建立一种用于快速、灵敏检测血清丙型肝炎病毒(HCV)核心抗原(HCcAg)含量的免疫新方法,并对其性能进行评价。方法采用新型纳米材料修饰电极,将HCV核心抗体固定到电极表面,制备检测HCV核心抗原的电化学免疫传感器,并分析该传感器的检测性能。结果该免疫传感器对HCV核心抗原反应灵敏,其线性范围为2.50~300.00ng/mL,相关系数为0.997,检出限为1.20ng/mL。此外,该传感器具有较好的准确性、选择性和精密度。结论该电化学免疫传感器性能良好,可实现对HCcAg的快速、灵敏检测。
作者 毛燕群
出处 《重庆医学》 CAS CSCD 北大核心 2012年第7期701-703,共3页 Chongqing medicine
  • 相关文献

参考文献9

二级参考文献54

  • 1杨朝国,陈川.丙型肝炎病毒感染的实验室检测及临床应用[J].国外医学(临床生物化学与检验学分册),2004,25(4):379-381. 被引量:9
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3刘艳,张贺秋,凌世淦,祁自柏.丙型肝炎病毒(HCV)培养模型的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):125-127. 被引量:5
  • 4[1]BendineUi M,Pistello M,Maggi F,et al.Blood-borne hepatitis viruses:hepatitis B,C,D,and G vimsos and Tr virus,In S.Specter,R.L.Hedinka,and S.A.Young(ed.),Clinical virology manumit.3rd ed.ASM Press,Washington,D.C,2000,306~337.
  • 5[2]Alter H.Discovery of non-A.non-B hepatitis and identification of its etiology[J].Am J Med,1999,107(Suppl.6B):16~20.
  • 6[3]Choo QL Kuo G,Weiner AJ,et al.Isolation of a eDNA clone derivedfrom ablood-borne non-A,non-B viral hepatitis gcnome[J].Science,1989,244:359~362.
  • 7[4]Lauer GM,Walker BD.Hepatitis C virus infection[J].N Engl J Med,2001,345:41~52.
  • 8[5]Kuo G,Choo QL Alter HJ,et al.An assay for circulating antibodies to a major etiologic virus of human non-A,non-B hepatitis.Sci-ence,1989,244:362~364.
  • 9[6]Alter HJ.New kit on the block:evaluation of second-generation assays for detection of antibody to the hepatitis C virus[J].Hepatology 1992,15:350~353.
  • 10[7]Greteh DR.Diagnestic tests for hepatitis C[J].Hepatology 1997,26(3Suppl.11:43~47.

共引文献61

同被引文献61

  • 1李立明.流行病学[M].6版.北京:人民卫生出版社,2007:338-339.
  • 2Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcino-ma incidence, mortality, and survival trends in the United Statesfrom 1975 to 2005 [J]. Journal of Clinical Oncology, 2009, 27(9):1485-1491.
  • 3SharifF MIF, Cox IJ, Gomaa Al, et al. Hepatocellular carcinoma: cur-rent trends in worldwide epidemiology, risk factors, diagnosis andtherapeutics [J]. Expert Review of Gastroenterology and Hepatolo-gy, 2009, 3(4): 353-367.
  • 4Tung HD, Wang JH, Tseng PL, et al. Neiftier Diabetes Mellitus norOverweight Is a Risk Factor for Hepatocellular Carcinoma in a Du-al HBV and HCV Endemic Area: Community Cross-Sectional andCase-Control Studies [J]. American Journal of Gastroenterology,2010, 105(8): 624-631.
  • 5Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics [J]. CA:Cancer Journal for Clinicians, 1999,49(1): 33-64.
  • 6Li YL, Chang SC, Goldstein BY, et al. Green tea consumption, in-fbmmation and the risk of primary hepatocellular carcinoma in aChinese population [J]. Cancer Epidemiology, 2011, 35(4): 362-368.
  • 7刘艳红,韩素桂.原发性肝癌570例血清HBV标志物检测分析[J].中国误诊医学,;2011,11 (13): 3109.
  • 8Raza SA, Clifford GM, Franceschi S. Worldwide variation in therelative importance or hepatitis B and hepatitis C viruses in hepato-cellular carcinoma: a systematic review [J], British Journal of Can-cer, 2007, 96(7): 1127-1134.
  • 9Chaudhry MA, Rizvi F, Afzal M, et al. Frequency of risk factors forhepatitis B (HBV) and hepatitis C virus (HCV) [J]. Ann Pak InstMed Sci, 2010, 6(3): 161-163.
  • 10Kataoka Y, Shao M, Wolski K, et al. Myeloperoxidase lev- els predict accelerated progression of coronary atheroscle- rosis in diabetic patients: insights from intravascular ul- trasound[J]. Atheroselerosis, 2014,232 (2) : 377-383.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部